VANCOUVER, British Columbia and ASHKELON, Israel, Oct. 24, 2022 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) (CSE: BYND) ("BYND Cannasoft" oregon the "Company") announced contiguous that it entered into a consulting work with Matrix Medika, a developer of aesculapian systems specialized successful assisting companies successful obtaining regulatory support for aesculapian devices nether development. The work volition beryllium fixed arsenic portion of the statement with Arkit Studio, a institution that provides the work of characterization and plan for the EZ-G Device.
Matrix Medika volition assistance BYND Cannasoft by granting adept sentiment and marketplace probe astir the regulatory support process for the Company’s EZ-G instrumentality successful Europe and the US, including FDA regulation, should specified support beryllium required. Matrix Medika has specialized successful the improvement of aesculapian systems since 2008. Its way grounds and familiarity with healthcare related regulatory processes and standards are expected to pb to shorter improvement cycles and better-quality power astatine a little cost. After receiving the opinion, BYND Cannasoft volition widen the consulting work with Matrix Medika for each phases of improvement of its EZ-G instrumentality from inception to see planning, design, development, and testing.
Last period BYND Cannasoft announced the acquisition of Zigi Carmel Initiatives & Investments Ltd., which holds the intelligence spot for the patent-pending EZ-G device. The EZ-G instrumentality is simply a CBD-based therapeutic instrumentality combined with proprietary bundle that regulates the travel of low-concentration CBD oils into the brushed tissues of the pistillate reproductive system.
BYND Cannasoft intends to prosecute the last registration of the patent and found a selling and income strategy for the EZ-G device. The Company's 'Go to Market' strategical program is based connected some B2B and B2C sales. Numerous studies person shown beneficial CBD enactment with the endocannabinoid system, a maestro regulatory strategy with receptors astir the body.
Yftah Ben Yaackov, CEO and Director of BYND, said, "Our committedness to our shareholders is to bring the EZ-G instrumentality to marketplace arsenic rapidly arsenic possible. Matrix Medika has worked with galore aesculapian companies and startups to assistance them with getting high-quality healthcare projects and bundle to marketplace rapidly and wrong budget. Some of the companies presently listed connected Matrix Medika's website see McKesson, NovelDSP, Sanara Ventures, Vibrant, Next Generation Technologies, and Novoxel. We judge their expertise successful aesculapian and technological regularisation volition let america to bring the EZ-G instrumentality to marketplace successful a overmuch much expeditious mode than we could connected our own."
About BYND Cannasoft Enterprises Inc.
BYND is an integrated software/cannabis company, based successful Israel.
CRM Software
BYND owns and markets a proprietary lawsuit narration absorption (CRM) bundle product, known arsenic “Benefit CRM”. BYND’s Benefit CRM bundle enables tiny and medium‐sized businesses to optimize their day‐to‐day concern activities specified arsenic income management, unit management, marketing, telephone halfway activities and plus management. BYND’s next-generation Benefit CRM level is present acceptable for BETA testing.
Cannabis CRM
Building connected its 20 years of acquisition successful CRM software, BYND has precocious begun improvement of an innovative caller CRM platform, designed specifically to service the needs of the aesculapian cannabis industry. This caller level volition beryllium the archetypal of its benignant for the aesculapian cannabis tract and the Company is assured it volition alteration the manufacture into a much organized, accessible, and terms transparent market. Data and accusation collected done the cognition of the Cannabis Farm (see below) and the products it produces volition let BYND to trial its caller Cannabis CRM level and set the level arsenic necessary. Additionally, operating the Cannabis Farm and selling aesculapian cannabis is expected to bring successful further gross to further enactment BYND during the archetypal roll‐out years of its cannabis CRM platform.
Medical Cannabis Business
BYND holds an archetypal support from the Medical Cannabis Unit successful the Ministry of Health of the State of Israel, for a contactless concern licence that allows trading successful aesculapian cannabis products without interaction with the existent substance. This is simply a unsocial licence that is held by lone a constricted fig of companies successful Israel. The Company is successful the last stages of obtaining the afloat licence and instantly aft receiving it, the Company plans to run done a licensed aesculapian cannabis workplace for the accumulation of the Company's backstage statement for assorted products and varieties. The products volition beryllium produced for the Company and marketed to the pharmacies portion paying a committee to the grower for the cultivation and processing of the substance. The Company anticipates that if the licence is received successful the coming months, it volition beryllium imaginable to marketplace the products instantly and seizure a important marketplace stock which tin make important income for the Company.
For further accusation delight notation to the Company’s website: www.cannasoft‐crm.com, the CSE’s website: www.thecse.com/en/listings/life-sciences/bynd-cannasoft-enterprises-inc and connected SEDAR: www.sedar.com.
Gabi Kabazo
Chief Financial Officer
Tel: (604) 833‐6820
e‐mail: ir@cannasoft‐crm.com
For Media and Investor Relations, delight contact:
David L. Kugelman
(866) 692-6847 Toll Free - U.S. & Canada
(404) 281-8556 Mobile and WhatsApp
Skype: kugsusa
Cautionary Note Regarding Forward‐Looking Statements
This property merchandise contains forward‐looking statements that impact risks and uncertainties, which whitethorn origin existent results to disagree materially from the statements made. When utilized successful this document, the words “may”, “would”, “could”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” and akin expressions are intended to place forward‐looking statements. The forward-looking statements successful this property merchandise include, without limitation, that the patents for the EZ-G instrumentality for which exertion has been made volition beryllium issued and volition screen each markets successful which it is intended that the EZ-G instrumentality volition beryllium sold, that each indispensable regulatory approvals to the merchantability of the EZ-G instrumentality volition beryllium obtained successful a timely manner, and that the Company volition person a afloat contactless concern licence that volition let trading successful aesculapian cannabis products without interaction with the substance, instantly pursuing which the Company volition run done a licensed aesculapian cannabis workplace for the accumulation of backstage statement products. Such statements bespeak the Company’s existent views with respect to aboriginal events and are taxable to specified risks and uncertainties. Many factors could origin existent results to disagree materially from the statements made, including unanticipated regulatory requests and delays, and those factors discussed successful filings made by the Company with the Canadian securities regulatory authorities, including (without limitation) successful the Company’s management’s treatment and investigation for the six period play ended June 30, 2022 and yearly accusation signifier dated October 8, 2022, which are disposable nether the Company’s illustration astatine www.sedar.com, and successful filings made with the U.S. Securities and Exchange Commission. Should 1 oregon much of these risks and uncertainties, specified arsenic currency and involvement complaint fluctuations, accrued competition, and wide economical and marketplace factors, hap oregon should assumptions underlying the forward-looking statements beryllium incorrect, existent results whitethorn alteration materially from those described herein arsenic intended, planned, anticipated, oregon expected. We bash not mean and bash not presume immoderate work to update these forward‐looking statements, but arsenic required by law. Shareholders are cautioned not to enactment undue reliance connected specified forward‐looking statements.
Neither the U.S. Securities and Exchange Commission nor the CSE has reviewed, approved oregon disapproved the contented of this property release.
/cdn.vox-cdn.com/uploads/chorus_asset/file/24020034/226270_iPHONE_14_PHO_akrales_0595.jpg)
English (US)